PRODUCTS
« BACK TO "INTERNATIONAL"
Nimodipine is indicated for the treatment of ischaemic neurological deficits following aneurysmal subarachnoid haemorrhage.
Nimodipine is a calcium channel blocker of the dihydropyridine group with preferential activity on cerebral vessels. Available For Selected Regions
Nimodipine is a calcium channel blocker of the dihydropyridine group with preferential activity on cerebral vessels. Available For Selected Regions